03-25-2025 11:56 AM CET |
Press release from: Insightace Analytic Pvt Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global gRNA Market Size, Share & Trends Analysis Report By Product & Services (Products, Custom gRNA Synthesis Services), gRNA Type (Research-Use, GMP-grade), Application (Genome Engineering, Disease Model Studies, Functional Genomics, Epigenetics, Others), End-use (Pharmaceutical & Biotechnology Companies, Academic Research Institutes, CMOs & CROs)- Market Outlook And Industry Analysis 2031"
The Global gRNA Market is valued at US$ 492.4 Mn in 2023, and it is expected to reach US$ 1,751.4 Mn by 2031, with a CAGR of 17.4% during the forecast period of 2024-2031.
Request for Sample Pages:
https://www.insightaceanalytic.com/request-sample/2735
The gRNA (guide RNA) market is rapidly advancing, propelled by breakthroughs in genetic engineering and the widespread adoption of CRISPR technology. As an integral element of the CRISPR-Cas9 system, gRNA directs the Cas9 enzyme to precise DNA sequences, facilitating accurate gene editing. This revolutionary technology is transforming disciplines such as medicine, agriculture, and biotechnology by enabling targeted therapies for genetic disorders, improved crop traits, and advanced functional genomics research.
The critical role of gRNA in achieving efficient genome modifications underscores its growing importance among scientists and researchers. With the increase in genetic diseases and a rising demand for personalized medicine, the need for high-quality gRNA is expanding. The market comprises various forms, including research-use gRNA and GMP-grade gRNA produced under stringent conditions for therapeutic applications. As the sector continues to grow, it opens up significant opportunities for innovation and collaboration, cementing its position at the forefront of genetic research and therapeutic development.
List of Prominent Players in the GRNA Market:
•Thermo Fisher Scientific Inc.
•Agilent Technologies Inc.
•System Biosciences, LLC.
•Jena Bioscience GmbH
•Merck KGaA
•GENEWIZ (Azenta Life Sciences)
•Takara Bio Inc.
•Synbio Technologies
•Horizon Discovery Ltd.
•Synthego
Market Dynamics:
Drivers-
The gRNA market is expanding rapidly, driven by the growing demand for precision medicine that requires targeted genetic modifications. gRNA is a critical component in CRISPR-based therapies for treating genetic disorders and cancers. Advances in biotechnology and genome editing tools are broadening gRNA's applications across healthcare, agriculture, and industrial biotechnology. Increased research and development efforts, bolstered by strategic collaborations and investments, further accelerate market growth. Moreover, the widespread adoption of next-generation sequencing (NGS) enhances gRNA's effectiveness in gene targeting and functional genomics, fueling additional market expansion.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2735
Challenges:
Despite its promising growth, the gRNA market faces several obstacles. Ethical and regulatory concerns regarding unintended consequences and the potential misuse of gene editing persist, as guidelines continue to evolve. Off-target effects, where gRNA inadvertently alters non-target genomic regions, present safety risks that necessitate improved specificity and delivery methods. Additionally, the inherent variability in gRNA specificity requires the design and validation of multiple gRNAs per target gene, complicating the gene-editing process and increasing the complexity of research efforts.
Regional Trends:
In North America, the gRNA market is driven by significant investments in R&D from major biotechnology companies such as Thermo Fisher Scientific, Merck KGaA, and Synthego. Increased research funding in genetic engineering and precision medicine supports rapid innovation and the expansion of gRNA applications in therapeutics. The region's robust healthcare infrastructure and strong collaborative networks between academia and industry further bolster market growth.
Recent Developments:
•In May 2023, Agilent Technologies (NYSE: A) announced plans to appeal the U.S. Patent and Trademarks Office (USPTO) Patent Trial and Appeal Board's (PTAB). The PTAB recently reversed the USPTO's initial decision on claims related to chemically modified synthetic CRISPR guide RNA.
•In Jan 2024, Synthego and SeQure Dx formed a strategic partnership to offer CRISPR therapeutics developers comprehensive off-target editing analysis services, featuring cutting-edge technology and turnkey end-to-end development solutions.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/2735
Segmentation of GRNA Market-
By Product & Services:
•Products
ogRNA Final Products
ogRNA Synthesis Products
gRNA Synthesis Kits
Plasmids
Others
•Custom gRNA Synthesis Services
By gRNA Type:
•Research-Use
•GMP-grade
By Application:
•Genome Engineering
•Disease Model Studies
•Functional Genomics
•Epigenetics
•Others
By End Use:
•Pharmaceutical & Biotechnology Companies
•Academic Research Institutes
•CMOs & CROs
By Region-
North America-
•The US
•Canada
•Mexico
Europe-
•Germany
•The UK
•France
•Italy
•Spain
•Rest of Europe
Asia-Pacific-
•China
•Japan
•India
•South Korea
•South East Asia
•Rest of Asia Pacific
Latin America-
•Brazil
•Argentina
•Rest of Latin America
Middle East & Africa-
•GCC Countries
•South Africa
•Rest of Middle East and Africa
Get more information: @
https://www.insightaceanalytic.com/report/grna-market/2735
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
This release was published on openPR.
